4SC AG INH. O.N./ DE000A3E5C40 /
| 9/20/2024 9:55:34 PM | Chg. -0.320 | Volume | Bid10:00:02 PM | Ask10:00:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 5.300EUR | -5.69% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 54.82 mill.EUR | 0.00% | - |
GlobeNewswire
12/5/2023
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
4/1/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
6/11/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018
